603716.SH
塞力医疗
SSE · Healthcare · Medical - Diagnostics & Research · CN
CNY 15.07
−4.86%Year over year
Reported trailing growth
- Revenue
- -39.8%
- EBITDA
- —
- EBIT
- +9.6%
- EPS
- +8.8%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -22.4%
- EBITDA
- -16.0%
- EBIT
- -3.7%
- Net income
- +0.9%
- EPS
- +4.6%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026